Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2014
06/18/2014CN101987848B New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing the same
06/18/2014CN101952275B Modulators for amyloid protein beta
06/18/2014CN101903372B Heteroaryl derivatives as orexin receptor antagonists
06/18/2014CN101405283B HIV inhibiting 5-amido substituted pyrimidines
06/17/2014US8754233 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
06/17/2014US8754226 Piperidinyl-substituted lactams as GPR119 modulators
06/17/2014US8754209 Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
06/17/2014US8754113 Oxadiazole derivative having endothelial lipase inhibitory activity
06/17/2014US8754107 Aminopyrrolidines as chemokine receptor antagonists
06/17/2014US8754074 Vinyl quinuclidine useful as a synthesis intermediate in the preparation of (R)-mequitazine
06/17/2014US8754053 Isoxazoline derivatives as insecticides
06/17/2014CA2699986C Anti-infective pyrimidines and uses thereof
06/17/2014CA2678907C Modulators of pharmacokinetic properties of therapeutics
06/17/2014CA2630273C Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
06/12/2014WO2014087298A1 Novel selective androgen receptor modulators
06/12/2014WO2014086894A1 Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
06/12/2014WO2014086865A1 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
06/12/2014WO2014086855A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086807A1 Novel pyrazine derivatives as cb2 receptor agonists
06/12/2014WO2014086806A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086805A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086734A1 N-(oxazol-2-yl)-aryl-carboxylic acid amides and use thereof as herbicides
06/12/2014WO2014086705A1 Novel pyridine derivatives
06/12/2014WO2014086701A1 Substituted thiazole compounds
06/12/2014WO2014086697A1 Substituted thiazole compounds
06/12/2014WO2014086478A1 Inhibitors of malt1 protease
06/12/2014WO2014086326A1 A method for the preparation and purification of new and known polymorphs and solvates of dasatinib
06/12/2014WO2014086316A1 Substituted pyridopyrazines as syk inhibitors
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014WO2014086098A1 Cyclohexane amine compound and application thereof for anti-schizophrenia drugs
06/12/2014WO2014047662A3 Indazole derivatives and uses thereof
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163032 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
06/12/2014US20140163031 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140163016 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
06/12/2014US20140163001 Heterocyclic compound
06/12/2014US20140162999 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof
06/12/2014US20140162998 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof
06/12/2014US20140162985 Heterocyclic nuclear hormone receptor modulators
06/12/2014US20140162361 Pyrimidine cyclohexyl glucocorticoid receptor modulators
06/12/2014US20140158956 Coloring matter compound, ink, resist composition for color filter, and heat-sensitive transfer recording sheet
06/12/2014US20140158955 Coloring matter compound, ink, resist composition for color filter, and heat-sensitive transfer recording sheet
06/11/2014EP2739621A1 2-acylaminothiazole compound crystals
06/11/2014EP2739615A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
06/11/2014EP2739612A1 Compounds and compositions for use in augmentation of glucose uptake and insulin secretion
06/11/2014CN103857675A Metalloenzyme inhibitor compounds
06/11/2014CN103857670A 2-oxo-piperidinyl derivatives
06/11/2014CN103848822A 1,8-carbazole derivative, preparation method and application thereof in luminescent device
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs
06/11/2014CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs
06/11/2014CN103848792A 4,4-disubstituted-dihydro-2-(1H)-quinazolinone as well as synthetic method and use thereof
06/11/2014CN102675302B Thiadiazole derivative containing 1,4-benzdioxanand preparation method and antibacterial activity thereof
06/11/2014CN102596936B Antiviral compounds
06/10/2014US8748627 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
06/10/2014US8748626 Oxazole and thiazole compounds as KSP inhibitors
06/10/2014US8748597 2,4-pyrimidinediamine compounds and their uses
06/10/2014US8748459 Pyridinoylpiperidines as 5-HT1F agonists
06/10/2014US8748442 sGC stimulators
06/10/2014US8748433 β3 adrenergic receptor agonists
06/10/2014CA2559740C Thiadiazolidinones as gsk-3 inhibitors
06/05/2014WO2014085600A1 Neuroprotective agents for treatment of neurodegenerative diseases
06/05/2014WO2014085153A1 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
06/05/2014WO2014084407A1 Dihydropyrone compounds and herbicides comprising the same
06/05/2014WO2014084330A1 Nitrogen-containing heterocyclic compound
06/05/2014WO2014082918A1 New indanyloxydihydrobenzofuranylacetic acids
06/05/2014WO2014082739A1 Substituted amino-arylcarboxamides as kcnq2/3 modulators
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014WO2014064714A3 Process for preparation of lurasidone hydrochloride
06/05/2014US20140155597 Amidine compound or salt thereof
06/05/2014US20140155433 Biaryl derivatives as nachr modulators
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155415 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes
06/05/2014US20140155413 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
06/05/2014US20140155408 Pyruvate kinase activators for use in therapy
06/05/2014US20140155404 Piperazinylpiperidine derivatives as chemokine receptor antagonists
06/05/2014US20140155402 Bi-heteroaryl compounds as vps34 inhibitors
06/05/2014US20140155401 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
06/05/2014US20140155390 Novel selective androgen receptor modulators
06/05/2014US20140155382 Anti-viral compounds
06/05/2014US20140155379 Heterocycle amines and uses thereof
06/05/2014US20140155377 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
06/05/2014US20140155370 Nuclear transport modulators and uses thereof
06/04/2014EP2738170A1 Heterocyclic compound
06/04/2014EP2738163A1 Amidine compound or salt thereof
06/04/2014EP2736905A1 Intermediate compounds and process for the preparation of lurasidone and salts thereof
06/04/2014EP2736904A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
06/04/2014EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/04/2014EP2736891A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) aminopropionic acid derivatives and their use as pharmaceuticals
06/04/2014EP2736886A1 Substituted quinolines and their use as medicaments
06/04/2014EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
06/04/2014CN103842360A N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
06/04/2014CN103842359A N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
06/04/2014CN103842358A Isothiazoline derivatives as insecticidal compounds
06/04/2014CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
06/04/2014CN103842347A Amide compound and use thereof for controlling harmful arthropods
06/04/2014CN103833745A New polycrystalline substance alpha form of dasatinib monohydrate and preparation method thereof
06/04/2014CN103833744A 1-ethyl pyrazole acrylonitrile compound and application thereof
06/04/2014CN103833743A Thiazolyl pyrazolyl acrylonitrile compound and application thereof
06/04/2014CN103833742A Pyrazolyl thiazolyl acrylonitrile compound and application thereof
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 628